Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLC
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Jun 2016 Status changed from not yet recruiting to completed.
- 06 Jul 2009 New trial record.